Barbara Jane O'Brien

Assistant Professor

  • 75 Citations
  • 4 h-Index
20142019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Barbara Jane O'Brien is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Glioblastoma Medicine & Life Sciences
Brain Neoplasms Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Lomustine Medicine & Life Sciences
Mefloquine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2014 2019

  • 75 Citations
  • 4 h-Index
  • 9 Article
  • 2 Chapter
  • 1 Review article
1 Citation (Scopus)

Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center

Harrison, R., Anderson, M. D., Cachia, D., Kamiya Matsuoka, C., Weathers, S-P., O'Brien, B. J., Penas-Prado, M., Yung, W. K. A., Wu, J., Yuan, Y. & de Groot, J. F., May 1 2019, In : European Journal of Cancer. 112, p. 83-93 11 p.

Research output: Contribution to journalArticle

Patient Participation
Glioblastoma
Clinical Trials
Neoplasms
Clinical Protocols
34 Citations (Scopus)

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Cloughesy, T. F., Mochizuki, A. Y., Orpilla, J. R., Hugo, W., Lee, A. H., Davidson, T. B., Wang, A. C., Ellingson, B. M., Rytlewski, J. A., Sanders, C. M., Kawaguchi, E. S., Du, L., Li, G., Yong, W. H., Gaffey, S. C., Cohen, A. L., Mellinghoff, I. K., Lee, E. Q., Reardon, D. A., O'Brien, B. J. & 10 others, Butowski, N. A., Nghiemphu, P. L., Clarke, J. L., Arrillaga-Romany, I. C., Colman, H., Kaley, T. J., de Groot, J. F., Liau, L. M., Wen, P. Y. & Prins, R. M., Mar 1 2019, In : Nature medicine. 25, 3, p. 477-486 10 p.

Research output: Contribution to journalArticle

Glioblastoma
Immunotherapy
T-cells
Tumors
Survival
3 Citations (Scopus)

Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma

Maraka, S., Groves, M. D., Mammoser, A. G., Melguizo-Gavilanes, I., Conrad, C. A., Tremont-Lukats, I. W., Loghin, M. E., O'Brien, B. J., Puduvalli, V. K., Sulman, E. P., Hess, K. R., Aldape, K. D., Gilbert, M. R., de Groot, J. F., Alfred Yung, W. K. & Penas-Prado, M., Feb 1 2019, In : Cancer. 125, 3, p. 424-433 10 p.

Research output: Contribution to journalArticle

temozolomide
Mefloquine
Memantine
Metformin
Glioblastoma
Melanoma
Survival
Therapeutics
Multivariate Analysis
Immunotherapy

Describing symptom burden and functional status at the diagnosis of leptomeningeal metastasis

Walker, J., O'Brien, B. J., Vera, E. & Armstrong, T., May 1 2018, In : Oncology nursing forum. 45, 3, p. 372-379 8 p.

Research output: Contribution to journalArticle

Neoplasm Metastasis
Neoplasms
Karnofsky Performance Status
Pain
Biological Therapy